Minimally-invasive Non-surgical Treatment in Teeth With Unfavourable Prognosis
Clinical and Radiographic Changes Following Minimally-invasive Non-surgical Therapy in Teeth With Unfavourable Prognosis: A Pilot Prospective Cohort Study
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
This is a pilot prospective cohort study to assess the efficacy of minimally-invasive non-surgical periodontal therapy (MINST) for the treatment of teeth with unfavourable periodontal prognosis. 20 patients who have teeth with unfavourable periodontal prognosis (due to bone loss to the apex or furcation involvement grade II C) will receive minimally-invasive non-surgical treatment (MINST) and will be reassessed up to 12 months after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2020
CompletedFirst Posted
Study publicly available on registry
January 22, 2020
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2023
CompletedJanuary 22, 2020
January 1, 2020
1.7 years
January 13, 2020
January 20, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Radiographic defect depth
defect depth measured in radiographs in mm (as measured on standardised radiographs)
baseline-12 months
Furcation involvement
furcation involvement measured clinically (as measured based on validated horizontal and vertical furcation involvement scales, by Hamp et al. 1975 and Tarnow 1984). Hamp et al. 1975 goes from 1 to 3 in increasing severity. Tarnow et al. score goes from A to C in increasing severity
baseline-12 months
Secondary Outcomes (5)
probing pocket depth
0-12 months
clinical attachment level
0-12 months
patient-reported outcomes
0-12 months
inflammatory response (in saliva and GCF)
0-12 months
subgingival microbes
0-12 months
Study Arms (1)
Minimally-invasive non-surgical therapy (MINST)
OTHERStudy treatment
Interventions
subgingival root debridement with a minimally-invasive approach using piezoelectric/ultrasonic instruments
Eligibility Criteria
You may qualify if:
- Age 18-70
- Diagnosis of Periodontitis stage III or IV (grade A, B or C) (Tonetti et al. 2018)
- Presence of:
- N=10: Maxillary or mandibular molars with:
- A. Furcation involvement degree II C based on Hamp et al. 1975 horizontal classification and Tarnow \& Fletcher 1984 vertical classification (with concomitant furcation involvement (FI) not exceeding degree II on the other aspects of the same tooth) B. gingival recession ≤ 2mm on furcation site C. mobility maximum degree 2
- N=10: 'Teeth with bone loss to the apex' (also defined as 'hopeless' by Cortellini et al. 2011), defined as having:
- A. radiographic bone loss to the apex or beyond the apex on at least one inter-dental aspect B. presence of severe attachment loss (\>10 mm) at the same inter-proximal site/s and at least at one of either the buccal or lingual aspect (Cortellini et al. 2011) C. lack of function because of hypermobility, and/or lack of chewing strength, and/or pain, and/or recurrent periodontal infection/abscesses (Cortellini et al. 2011) D. positive response to vitality testing with electric pulp test (EPT) or previous endodontic treatment considered satisfactory, as judged by the examining clinician
- \- Willing to sign informed consent to take part in the study
You may not qualify if:
- Smoking (any current or in past 5 years)
- Medical history including diabetes or hepatic or renal disease, or other serious medical conditions or transmittable disease
- History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
- Anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam
- Systemic antibiotic therapy during the 3 months preceding the baseline exam
- History of alcohol or drug abuse, vii) Self-reported pregnancy or lactation
- Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that according to the investigator may increase the risk associated with trial participation
- Periodontal treatment to the study site within the last 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2020
First Posted
January 22, 2020
Study Start
February 1, 2020
Primary Completion
October 31, 2021
Study Completion
October 31, 2023
Last Updated
January 22, 2020
Record last verified: 2020-01